Search research articles
Contact Us
Filters
Showing results (801-810 of 1,145) with videos related to
Page
of 115
Sort By:
Genes, Chromosomes & Cancer
|
September 26, 2024
17p13 (TP53) Deletions Are Associated With an Aggressive Phenotype but Unrelated to Patient Prognosis in Urothelial Bladder Carcinomas
Martina Kluth, Melanie Hitzschke, Kira Furlano, et al.
BMC Cancer
|
April 14, 2025
Loss of chromosome Y is unrelated to the composition of the tumor microenvironment and patient prognosis in muscle-invasive urothelial bladder cancers
Henning Plage, Viktoria Ahlburg, Sebastian Hofbauer, et al.
Stem Cell Research & Therapy
|
September 5, 2022
Translational development of ABCB5<sup>+</sup> dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers
Andreas Kerstan, Kathrin Dieter, Elke Niebergall-Roth, et al.
Virchows Archiv : an International Journal of Pathology
|
June 15, 2025
High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumors
Viktoria Chirico, Fatih Baybars Ergüven, Katharina Möller, et al.
Diagnostics (Basel, Switzerland)
|
August 14, 2025
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor Phenotype
Viktoria Chirico, Hena Sharifi, Maria Christina Tsourlakis, et al.
British Journal of Cancer
|
July 9, 2014
Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment
L A Kluth, F Abdollah, E Xylinas, et al.
Plos One
|
January 24, 2025
Correction: High prevalence of p16 staining in malignant tumors
Noémi De Wispelaere, Sebastian Dwertmann Rico, Marcus Bauer, et al.
BMC Urology
|
April 24, 2024
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors
Henning Plage, Kira Furlano, Sebastian Hofbauer, et al.
Biomarker Research
|
December 10, 2024
Prevalence and clinical significance of Claudin-3 expression in cancer: a tissue microarray study on 14,966 tumor samples
Seyma Büyücek, Nina Schraps, Anne Menz, et al.
Diagnostic Pathology
|
January 13, 2024
Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities
Florian Viehweger, Carola Böcker, Sören Weidemann, et al.
Page
of 115
Search research articles
Search
Showing results (801-810 of 1,145) with videos related to
Sort By:
Page
of 115
Genes, Chromosomes & Cancer
|
September 26, 2024
17p13 (TP53) Deletions Are Associated With an Aggressive Phenotype but Unrelated to Patient Prognosis in Urothelial Bladder Carcinomas
Martina Kluth, Melanie Hitzschke, Kira Furlano, et al.
BMC Cancer
|
April 14, 2025
Loss of chromosome Y is unrelated to the composition of the tumor microenvironment and patient prognosis in muscle-invasive urothelial bladder cancers
Henning Plage, Viktoria Ahlburg, Sebastian Hofbauer, et al.
Stem Cell Research & Therapy
|
September 5, 2022
Translational development of ABCB5<sup>+</sup> dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers
Andreas Kerstan, Kathrin Dieter, Elke Niebergall-Roth, et al.
Virchows Archiv : an International Journal of Pathology
|
June 15, 2025
High mobility group protein 2 (HMGA2) is highly expressed in a broad range of benign and malignant tumors
Viktoria Chirico, Fatih Baybars Ergüven, Katharina Möller, et al.
Diagnostics (Basel, Switzerland)
|
August 14, 2025
HMGB1 Deficiency Occurs in a Broad Range of Human Cancers and Is Often Associated with Unfavorable Tumor Phenotype
Viktoria Chirico, Hena Sharifi, Maria Christina Tsourlakis, et al.
British Journal of Cancer
|
July 9, 2014
Clinical nodal staging scores for prostate cancer: a proposal for preoperative risk assessment
L A Kluth, F Abdollah, E Xylinas, et al.
Plos One
|
January 24, 2025
Correction: High prevalence of p16 staining in malignant tumors
Noémi De Wispelaere, Sebastian Dwertmann Rico, Marcus Bauer, et al.
BMC Urology
|
April 24, 2024
PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors
Henning Plage, Kira Furlano, Sebastian Hofbauer, et al.
Biomarker Research
|
December 10, 2024
Prevalence and clinical significance of Claudin-3 expression in cancer: a tissue microarray study on 14,966 tumor samples
Seyma Büyücek, Nina Schraps, Anne Menz, et al.
Diagnostic Pathology
|
January 13, 2024
Prostein expression in human tumors: a tissue microarray study on 19,202 tumors from 152 different Tumor entities
Florian Viehweger, Carola Böcker, Sören Weidemann, et al.
Page
of 115